This is the authors' abstract. We don't add key points for this paper.
We present catalyst-free “green” site-selective protein bioconjugations that utilise aldol condensations and are compatible with click chemistries, and construct a nanobody-derived bioconjugate capable of selectively labelling prostate cancer cells.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yates et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: